AAAAAA

   
Results: 1-9 |
Results: 9
GENESIS OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS (MRSA), HOW TREATMENT OF MRSA INFECTIONS WAS SELECTED FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM, AND THE IMPORTANCE OF ANTIBIOTIC MANAGEMENT AND INFECTION-CONTROL
Authors: SCHENTAG JJ HYATT JM CARR JR PALADINO JA BIRMINGHAM MC ZIMMER GS CUMBO TJ
Citation: Jj. Schentag et al., GENESIS OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS (MRSA), HOW TREATMENT OF MRSA INFECTIONS WAS SELECTED FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM, AND THE IMPORTANCE OF ANTIBIOTIC MANAGEMENT AND INFECTION-CONTROL, Clinical infectious diseases, 26(5), 1998, pp. 1204-1214
ASSESSING ANTIBACTERIAL PHARMACOECONOMICS IN THE INTENSIVE-CARE UNIT
Authors: BIRMINGHAM MC HASSETT JM SCHENTAG JJ PALADINO JA
Citation: Mc. Birmingham et al., ASSESSING ANTIBACTERIAL PHARMACOECONOMICS IN THE INTENSIVE-CARE UNIT, PharmacoEconomics, 12(6), 1997, pp. 637-647
CHANGING THE INFECTION-CONTROL PARADIGM FROM OFF-LINE TO REAL-TIME - THE EXPERIENCE AT MILLARD-FILLMORE-HEALTH-SYSTEM
Authors: CARR JR FITZPATRICK P IZZO JL CUMBO TJ BIRMINGHAM MC ADELMAN MH PALADINO JA HANSON SC SCHENTAG JJ
Citation: Jr. Carr et al., CHANGING THE INFECTION-CONTROL PARADIGM FROM OFF-LINE TO REAL-TIME - THE EXPERIENCE AT MILLARD-FILLMORE-HEALTH-SYSTEM, Infection control and hospital epidemiology, 18(4), 1997, pp. 255-259
FORMULARY MANAGEMENT VS DISEASE MANAGEMENT
Authors: SCHENTAG JJ CARR JR ADELMAN MH BIRMINGHAM MC PALADINO JA ZIMMER G CUMBO TJ
Citation: Jj. Schentag et al., FORMULARY MANAGEMENT VS DISEASE MANAGEMENT, Infectious diseases in clinical practice, 5, 1996, pp. 42-47
A 2ND LARGE CONTROLLED CLINICAL-STUDY OF E5, A MONOCLONAL-ANTIBODY TOENDOTOXIN - RESULTS OF A PROSPECTIVE, MULTICENTER, RANDOMIZED, CONTROLLED TRIAL
Authors: BONE RC BALK RA FEIN AM PERL TM WENZEL RP REINES HD QUENZER RW IBERTI TJ MACINTYRE N SCHEIN RMH TRENHOLME G NIEDERMAN M CHALFIN D ABALOS A OROPELLO J EMPSON P CAMINITII S GREENMAN R BOOTH F PLOUFFE J RUSSELL J GIANAKOPOULOS G IANNINI P HINDES R COBLENS K KOHLER R MARTIN M BERNARD G EDWARDS J CRISLIP M FILLER S NASRAWAY SA SIGEL PK SOTTILE FD MARTIN DH DEBOISBLANC BP CHANDRASEKAR PH BROUGHTON WA MIDDLETON RM SEIBERT AF EMMANUEL G LIE TH ANDERSON CLV PANKEY GA ANDERSON P OLSEN K SANPEDRO GS GRAHAM D GROSSMAN J WELS PB SCHENTAG J BIRMINGHAM MC MCGRATH B TUAZON C CONRY K BELLO E MCCUE JM ELLRODT G STEIN S RIEDINGER M CHMEL H TONEY J YANGCO B RACKOW E ASTIZ ME CARPATI C JACOBS R HOLCROFT J BAGLEY M VASSAR MJ GOTTLIEB J KUBIS J CHAMBERS H LIEBLER J BROWN A MCCAFFREE R WEDEL N HANNIGAN J NELSON BJ SARIA EA JONES H ACKERMAN S SCANNON P WEBB CD
Citation: Rc. Bone et al., A 2ND LARGE CONTROLLED CLINICAL-STUDY OF E5, A MONOCLONAL-ANTIBODY TOENDOTOXIN - RESULTS OF A PROSPECTIVE, MULTICENTER, RANDOMIZED, CONTROLLED TRIAL, Critical care medicine, 23(6), 1995, pp. 994-1006
MATHEMATICAL EXAMINATION OF DUAL INDIVIDUALIZATION PRINCIPLES .2. THERATE OF BACTERIAL ERADICATION AT THE SAME AREA UNDER THE INHIBITORY CURVE IS MORE RAPID FOR CIPROFLOXACIN THAN FOR CEFMENOXIME
Authors: GOSS TF FORREST A NIX DE BALLOW CH BIRMINGHAM MC CUMBO TJ SCHENTAG JJ
Citation: Tf. Goss et al., MATHEMATICAL EXAMINATION OF DUAL INDIVIDUALIZATION PRINCIPLES .2. THERATE OF BACTERIAL ERADICATION AT THE SAME AREA UNDER THE INHIBITORY CURVE IS MORE RAPID FOR CIPROFLOXACIN THAN FOR CEFMENOXIME, The Annals of pharmacotherapy, 28(7-8), 1994, pp. 863-868
THE DEVELOPMENT OF A BEDSIDE ALGORITHM CAPABLE OF TARGETING ANTI-ENDOTOXINS TO THE RESPONDER SUBPOPULATIONS
Authors: BIRMINGHAM MC NIX DE CUMBO TJ COLLINS DA WELS PB SCHENTAG JJ
Citation: Mc. Birmingham et al., THE DEVELOPMENT OF A BEDSIDE ALGORITHM CAPABLE OF TARGETING ANTI-ENDOTOXINS TO THE RESPONDER SUBPOPULATIONS, Therapeutic drug monitoring, 15(6), 1993, pp. 503-509
DEVELOPMENT OF A POPULATION PHARMACOKINETIC MODEL AND OPTIMAL SAMPLING STRATEGIES FOR INTRAVENOUS CIPROFLOXACIN
Authors: FORREST A BALLOW CH NIX DE BIRMINGHAM MC SCHENTAG JJ
Citation: A. Forrest et al., DEVELOPMENT OF A POPULATION PHARMACOKINETIC MODEL AND OPTIMAL SAMPLING STRATEGIES FOR INTRAVENOUS CIPROFLOXACIN, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 1065-1072
PHARMACODYNAMICS OF INTRAVENOUS CIPROFLOXACIN IN SERIOUSLY ILL-PATIENTS
Authors: FORREST A NIX DE BALLOW CH GOSS TF BIRMINGHAM MC SCHENTAG JJ
Citation: A. Forrest et al., PHARMACODYNAMICS OF INTRAVENOUS CIPROFLOXACIN IN SERIOUSLY ILL-PATIENTS, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 1073-1081
Risultati: 1-9 |